Lee_2023_Pharmaceuticals.(Basel)_16_

Reference

Title : Neuroprotective Effects of Davallia mariesii Roots and Its Active Constituents on Scopolamine-Induced Memory Impairment in In Vivo and In Vitro Studies - Lee_2023_Pharmaceuticals.(Basel)_16_
Author(s) : Lee CH , Ko MS , Kim YS , Ham JE , Choi JY , Hwang KW , Park SY
Ref : Pharmaceuticals (Basel) , 16 : , 2023
Abstract : Beta-amyloid (Abeta) proteins, major contributors to Alzheimer's disease (AD), are overproduced and accumulate as oligomers and fibrils. These protein accumulations lead to significant changes in neuronal structure and function, ultimately resulting in the neuronal cell death observed in AD. Consequently, substances that can inhibit Abeta production and/or accumulation are of great interest for AD prevention and treatment. In the course of an ongoing search for natural products, the roots of Davallia mariesii T. Moore ex Baker were selected as a promising candidate with anti-amyloidogenic effects. The ethanol extract of D. mariesii roots, along with its active constituents, not only markedly reduced Abeta production by decreasing beta-secretase expression in APP-CHO cells (Chinese hamster ovary cells which stably express amyloid precursor proteins), but also exhibited the ability to diminish Abeta aggregation while enhancing the disaggregation of Abeta aggregates, as determined through the Thioflavin T (Th T) assay. Furthermore, in an in vivo study, the extract of D. mariesii roots showed potential (a tendency) for mitigating scopolamine-induced memory impairment, as evidenced by results from the Morris water maze test and the passive avoidance test, which correlated with reduced Abeta deposition. Additionally, the levels of acetylcholine were significantly elevated, and acetylcholinesterase levels significantly decreased in the brains of mice (whole brains). The treatment with the extract of D. mariesii roots also led to upregulated brain-derived neurotrophic factor (BDNF) and phospho-cAMP response element-binding protein (p-CREB) in the hippocampal region. These findings suggest that the extract of D. mariesii roots, along with its active constituents, may offer neuroprotective effects against AD. Consequently, there is potential for the development of the extract of D. mariesii roots and its active constituents as effective therapeutic or preventative agents for AD.
ESTHER : Lee_2023_Pharmaceuticals.(Basel)_16_
PubMedSearch : Lee_2023_Pharmaceuticals.(Basel)_16_
PubMedID: 38004471

Related information

Citations formats

Lee CH, Ko MS, Kim YS, Ham JE, Choi JY, Hwang KW, Park SY (2023)
Neuroprotective Effects of Davallia mariesii Roots and Its Active Constituents on Scopolamine-Induced Memory Impairment in In Vivo and In Vitro Studies
Pharmaceuticals (Basel) 16 :

Lee CH, Ko MS, Kim YS, Ham JE, Choi JY, Hwang KW, Park SY (2023)
Pharmaceuticals (Basel) 16 :